tg-me.com/Smithsonian/8828
Create:
Last Update:
Last Update:
Personalized Melanoma Vaccine Could Be a 'Game Changer' by Teaching the Body to Fight Cancer Cells
BY Smithsonian
Share with your friend now:
tg-me.com/Smithsonian/8828
tg-me.com/Smithsonian/8828
Share with your friend now:
tg-me.com/Smithsonian/8828
View MORE
Open in Telegram
Smithsonian Telegram | DID YOU KNOW?
Date: | Smithsonian
The seemingly negative pandemic effects and resource/product shortages are encouraging and allowing organizations to innovate and change.The news of cash-rich organizations getting ready for the post-Covid growth economy is a sign of more than capital spending plans. Cash provides a cushion for risk-taking and a tool for growth.
At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?
Smithsonian from us